Aromatase is also observed in breast cancer stromal adipocytes of obese postmenopausal women, and several studies have identified mechanistic associations between obesity, inflammation, elevated aromatase, and breast cancer development [46,59,60]. This evidence concerns the gene CYP19A1 and obesity due to melanocortin 4 receptor deficiency.